They providemarketableproducts that can be producedbysmall-scale, householdproductionsystems, and are generally of highervalueand less vulnerable tocriticalharvesttimingthanmanycrops.
As with most marketable currencies, equity in a biotech can suffer from deviations from this underlying data-supported value, which can result in over-pricing of assets that lack the intrinsic quality or robustness.